The FDA has approved updated COVID-19 vaccines from Pfizer and Moderna, targeting the KP.2 strain. With rising infections and respiratory virus season approaching, health officials urge vaccination for all eligible individuals aged six months and older. Vaccines are expected to be available shortly.